DoD Peer Reviewed Orthopaedic Rehabilitation Clinical Consortium Award

The summary for the DoD Peer Reviewed Orthopaedic Rehabilitation Clinical Consortium Award grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Dept of the Army USAMRAA, which is the U.S. government agency offering this grant.

DoD Peer Reviewed Orthopaedic Rehabilitation Clinical Consortium Award: The intent of the award is to fund clinical rehabilitation studies focused on improving functional outcomes of severe musculoskeletal injuries associated with military combat. The award is designed to bring together populations of military orthopaedic trauma patients, the combat-relevant research expertise of the specified military treatment facilities (MTFs) listed in Section B.2, and the patient populations and research expertise of highly qualified civilian rehabilitation scientists (i.e. from the fields of physical medicine, physical therapy, occupational therapy, and/or orthopaedic trauma) at outstanding organizations. It is expected that relevant clinical outcomes will require longitudinal evaluations of rehabilitation and return to optimal function. At the time of award completion, it is anticipated that the awardee will have established a strong infrastructure for continuing clinical studies on combat-relevant musculoskeletal injuries, and products (information, guidelines, validated techniques, or devices) that result in changes to, or validation of, current clinical practice that lead to better outcomes for our injured warriors. All projects should account for financial costs and provide detailed estimates of the proposed system cost if procured, so that the military and civilian medical community can conduct a cost benefit analysis with current practice alternative to distinguish the optimal cost-effective treatments.